1alpha, 24, 25-Trihydroxy VD2(457048-34-9)
- Name: 1alpha, 24, 25-Trihydroxy VD2
- Synonyms:CS-0807;1alpha,24,25-Trihydroxy VD2;
- Molecular Formula:C28H44O4
- Molecular Weight:444.65
- CAS Registry Number:457048-34-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.457048-34-9 1alpha, 24, 25-Trihydroxy VD2
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.457048-34-9 1alpha, 24, 25-Trihydroxy VD2
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1alpha, 24, 25-Trihydroxy VD2
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.457048-34-9 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24,25-tetrol,(1a,3b,5Z,7E,22E,25x)-;457048-34-9
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
CAS No.457048-34-9 1伪, 24, 25-Trihydroxy VD2
Assay:>98% Package:inquiry Transportation:inquiry Application:1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.
Min. Order:0
Supplier:BOC Sciences [
United States]
CAS No.457048-34-9 1alpha,24,25-Trihydroxy VD2
Assay:98% Package:According to the demand of customer Storage:Sealed, dry, microtherm , avoid light and smell. Transportation:by air or by sea Application:Organic synthesis
Min. Order:0
Supplier:Henan Allgreen Chemical Co.,Ltd [
China (Mainland)]

Other Product
- 330450-45-8/b-AP15
- 1232030-35-1/Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]-
- 198414-31-2/17alpha-Acetoxy-11beta-[4-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene- 3,20-dione
- 58322-11-5/(1R,3aR,7aR)-1-((2R,5S)-5,6-dimethylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one
- 39932-44-0/25-Hydroxytachysterol3
- 406228-55-5/A-385358
- 243982-55-0/PDHK inhibitor
- 105910-05-2/(E)-ethyl 3-(4-methyl-2-nitrophenyl)acrylate
- 1341224-83-6/INCB8761(PF-4136309)
- 1221485-83-1/Skepinone-L
- 183365-34-6/OSI-413
- 1227939-82-3/ABT-348
- 1116743-46-4/SAR125844
- 334949-59-6/(3Z)-3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indole-6-carboxamide
- 1356059-82-9/GTx-134
- 169939-93-9/LY-333531
- 942936-75-6/Phen-DC 3
- 329227-30-7/4-chloro-5-[(2E)-2-(4-hydroxy-3-nitrobenzylidene)hydrazinyl]pyridazin-3-ol
- 960374-59-8/PR 957
- 457048-34-9/1alpha, 24, 25-Trihydroxy VD2
- 960293-88-3/BI605906
- 1294517-97-7/Impurity A of Tacalcitol
- 163768-50-1/Auristatin F
- 183387-50-0/HE3235
- 213400-34-1/UPF 648
- 259746-53-7/P-2045
- 1311367-27-7/BIX-02565
- 349085-38-7/2-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)-N-(4-ISOPROPYLPHENYL)ACETAMIDE
- 82266-85-1/(6aR,7R,9aR)-11-((3S,5R)-3,5-dihydroxy-2-Methylcyclohex-1-en-1-yl)-6a-Methyl-7-((R)-6-Methylheptan-2-yl)-2-phenyl-4a,5,6,6a,7,8,9,9a-octahydrocyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H,11H)-dione
- 851627-80-0/Benzamide, 2-[(2-bromoethyl)[2-[(methylsulfonyl)oxy]ethyl]amino]-3,5-dinitro-N-[2-(phosphonooxy)ethyl]-, monosodium salt (9CI)